In this study, the effect of
melatonin on
sodium arsenite (
arsenite)-induced peripheral neurotoxicity was investigated using dorsal root ganglion (DRG) explants. After 24-hr incubation,
arsenite (30 microm) consistently elevated the expression of
heat shock protein 70 and haeme oxygenase-1, two well-known
stress proteins, in the treated DRG explants. Co-incubation with
melatonin (4 and 20 mm) concentration-dependently attenuated
arsenite-induced elevation in
stress proteins. Furthermore,
melatonin inhibited
arsenite-induced phosphorylation of p38 and DNA fragmentation. Inhibition by
melatonin of
arsenite-induced apoptosis was mediated via inactivating both endoplasmic reticulum (ER) and mitochondrial pathways. In the ER pathway,
melatonin suppressed
arsenite-induced elevation in activating transcription factor-6 and
CCAAT/enhancer-binding protein homologous
protein in the nuclear fraction of the treated DRG explants. Moreover,
melatonin attenuated
arsenite-induced activation of
caspase 12, an ER-specific
enzyme. In the mitochondrial pathway,
arsenite-induced increases in Bcl-2 levels and cytosolic
cytochrome c were reduced by
melatonin. At the same time,
melatonin inhibited
arsenite-induced activation of
caspase 3 in the treated DRG explants. Compared with
glutathione and N-acetyl
cysteine,
melatonin was more potent than either in inhibiting
arsenite-induced elevation in
stress proteins. Taken together, our study demonstrates that
melatonin is protective against
arsenite-induced neurotoxicity in DRG explants. In addition,
melatonin prevented
arsenite-induced apoptosis via suppression of ER and mitochondrial activation. Our data suggest that
melatonin is potentially a
therapy for
arsenite-induced
peripheral neuropathy.